{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:30:04Z","timestamp":1793237404541,"version":"4.5.0"},"reference-count":238,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>In the intricate realm of interactions between hosts and pathogens, Toll-like receptors (TLRs), which play a crucial role in the innate immune response, possess the ability to identify specific molecular signatures. This includes components originating from pathogens such as SARS-CoV-2, as well as the resulting damage-associated molecular patterns (DAMPs), the endogenous molecules released after cellular damage. A developing perspective suggests that TLRs play a central role in neuroinflammation, a fundamental factor in neurodegenerative conditions like Alzheimer\u2019s and Parkinson\u2019s disease (PD). This comprehensive review consolidates current research investigating the potential interplay between TLRs, their signaling mechanisms, and the processes of neurodegeneration following SARS-CoV-2 infection with an aim to elucidate the involvement of TLRs in the long-term neurological complications of COVID-19 and explore the potential of targeting TLRs as a means of implementing intervention strategies for the prevention or treatment of COVID-19-associated long-term brain outcomes.<\/jats:p>","DOI":"10.3389\/fmed.2025.1458281","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T09:57:33Z","timestamp":1742983053000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of toll-like receptors in post-COVID-19 associated neurodegenerative disorders?"],"prefix":"10.3389","volume":"12","author":[{"given":"Senthil Kumaran","family":"Satyanarayanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsz Fung","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huachen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suki Man Yan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"ref1","year":"2023"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long Covid: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul Covid","volume":"23","author":"Mehandru","year":"2022","journal-title":"Nat Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute Covid-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1038\/s41380-023-02171-3","article-title":"Epidemiology, clinical presentation, pathophysiology, and management of long Covid: an update","volume":"28","author":"Su","year":"2023","journal-title":"Mol Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.1038\/s41467-023-41941-z","article-title":"Viral kinetics of sequential Sars-CoV-2 infections","volume":"14","author":"Kissler","year":"2023","journal-title":"Nat Commun"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"100630","DOI":"10.1016\/j.lanepe.2023.100630","article-title":"Differences in incidence, nature of symptoms, and duration of long Covid among hospitalised migrant and non-migrant patients in the Netherlands: a retrospective cohort study","volume":"29","author":"Chilunga","year":"2023","journal-title":"Lancet Regional Health \u2013Europe"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00415-020-10070-8","article-title":"Covid-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?","volume":"268","author":"Ferini-Strambi","year":"2021","journal-title":"J Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13195-020-00640-3","article-title":"Immediate and long-term consequences of Covid-19 infections for the development of neurological disease","volume":"12","author":"Heneka","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S2215-0366(20)30462-4","article-title":"Bidirectional associations between Covid-19 and psychiatric disorder: retrospective cohort studies of 62\u2008354 Covid-19 cases in the Usa","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"100476","DOI":"10.1016\/j.waojou.2020.100476","article-title":"Enhancing innate immunity against virus in times of Covid-19: trying to untangle facts from fictions","volume":"13","author":"Larenas-Linnemann","year":"2020","journal-title":"World Allergy Organ J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the Covid-19 virus targeting the Cns: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms","volume":"11","author":"Baig","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"ref13","first-page":"42","article-title":"Neurological manifestation in Covid-19 disease with neuroimaging studies","volume":"12","author":"Ghaderi","year":"2023","journal-title":"Am J Neurodegener Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1172416","DOI":"10.3389\/fneur.2023.1172416","article-title":"Covid-19 and neurological disorders: what might connect Parkinson's disease to Sars-CoV-2 infection","volume":"14","author":"Iacono","year":"2023","journal-title":"Front Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1093\/brain\/awaa240","article-title":"The emerging spectrum of Covid-19 neurology: clinical, radiological and laboratory findings","volume":"143","author":"Paterson","year":"2020","journal-title":"Brain"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"112189","DOI":"10.1016\/j.celrep.2023.112189","article-title":"Sars-CoV-2 spike protein induces Tlr4-mediated long-term cognitive dysfunction recapitulating post-Covid-19 syndrome in mice","volume":"42","author":"Fontes-Dantas","year":"2023","journal-title":"Cell Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.bbi.2020.10.007","article-title":"Role of astroglial toll-like receptors (Tlrs) in central nervous system infections, injury and neurodegenerative diseases","volume":"91","author":"Li","year":"2021","journal-title":"Brain Behav Immun"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"13078","DOI":"10.1038\/s41598-023-40114-8","article-title":"The role of Tlr7 agonists in modulating Covid-19 severity in subjects with loss-of-function Tlr7 variants","volume":"13","author":"Naushad","year":"2023","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"13144","DOI":"10.1038\/s41598-023-39698-y","article-title":"Central nervous system biomarkers Gfap and NfL associate with post-acute cognitive impairment and fatigue following critical Covid-19","volume":"13","author":"Bark","year":"2023","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1038\/s41467-022-34068-0","article-title":"Severe neuro-Covid is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study","volume":"13","author":"Etter","year":"2022","journal-title":"Nat Commun"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.immuni.2020.12.011","article-title":"Neurological manifestations of Covid-19 feature T cell exhaustion and dedifferentiated monocytes in cerebrospinal fluid","volume":"54","author":"Heming","year":"2021","journal-title":"Immunity"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1021\/acsinfecdis.2c00204","article-title":"Two years into the Covid-19 pandemic: lessons learned","volume":"8","author":"Da Silva","year":"2022","journal-title":"Acs Infectious Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of Sars-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00784-023-05078-z","article-title":"The role of the oral cavity in Sars-CoV-2- and other viral infections","volume":"27","author":"Hoffmann","year":"2023","journal-title":"Clin Oral Investig"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e26577","DOI":"10.1016\/j.heliyon.2024.e26577","article-title":"Sars-CoV-2 mechanisms of cell tropism in various organs considering host factors","volume":"10","author":"Behboudi","year":"2024","journal-title":"Heliyon"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"Sars-CoV-2 cell entry depends on Ace2 and Tmprss2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"21415","DOI":"10.1038\/s41598-020-78402-2","article-title":"Sars-CoV-2 receptor Ace2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress","volume":"10","author":"Wruck","year":"2020","journal-title":"Sci Rep"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1038\/s41467-023-40228-7","article-title":"Neuroinvasion and anosmia are independent phenomena upon infection with Sars-CoV-2 and its variants","volume":"14","author":"De Melo","year":"2023","journal-title":"Nat Commun"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00401-021-02314-2","article-title":"The olfactory nerve is not a likely route to brain infection in Covid-19: a critical review of data from humans and animal models","volume":"141","author":"Butowt","year":"2021","journal-title":"Acta Neuropathol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"674123","DOI":"10.3389\/fncel.2021.674123","article-title":"Expression of the Ace2 virus entry protein in the Nervus terminalis reveals the potential for an alternative route to brain infection in Covid-19","volume":"15","author":"Bilinska","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","article-title":"Sars-CoV-2 is associated with changes in brain structure in Uk biobank","volume":"604","author":"Douaud","year":"2022","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.15.21251511","article-title":"Mapping of Sars-CoV-2 brain invasion and histopathology in Covid-19 disease","author":"Serrano","year":"2021","journal-title":"medRxiv"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.160277","article-title":"Sars-CoV-2 infection of sustentacular cells disrupts olfactory signaling pathways","volume":"7","author":"Verma","year":"2022","journal-title":"JCI Insight"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41423-023-01119-5","article-title":"Olfactory immune response to Sars-CoV-2","volume":"21","author":"Wellford","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41392-021-00591-7","article-title":"The olfactory route is a potential way for Sars-CoV-2 to invade the central nervous system of rhesus monkeys","volume":"6","author":"Jiao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/ane.13657","article-title":"Potential mechanism of Sars-CoV-2-associated central and peripheral nervous system impairment","volume":"146","author":"Zhang","year":"2022","journal-title":"Acta Neurol Scand"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","article-title":"Olfactory transmucosal Sars-CoV-2 invasion as a port of central nervous system entry in individuals with Covid-19","volume":"24","author":"Meinhardt","year":"2021","journal-title":"Nat Neurosci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"115321","DOI":"10.1016\/j.biopha.2023.115321","article-title":"Role of Sars-Cov-2 and Ace2 in the pathophysiology of peripheral vascular diseases","volume":"166","author":"Tanzadehpanah","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cell.2022.11.030","article-title":"Sars-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming","volume":"186","author":"Wu","year":"2023","journal-title":"Cell"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.4103\/1673-5374.327323","article-title":"Sars-CoV-2 involvement in central nervous system tissue damage","volume":"17","author":"Haidar","year":"2022","journal-title":"Neural Regen Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41392-021-00818-7","article-title":"Neurological complications and infection mechanism of Sars-Cov-2","volume":"6","author":"Wan","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12974-022-02579-8","article-title":"COVID-19 and cognitive impairment: neuroinvasive and blood\u2013brain barrier dysfunction","volume":"19","author":"Chen","year":"2022","journal-title":"J Neuroinflammation"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.3390\/ijms22052681","article-title":"Interactions of SARS-CoV-2 with the blood\u2013brain barrier","volume":"22","author":"Erickson","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","article-title":"Blood\u2013brain barrier disruption and sustained systemic inflammation in individuals with long Covid-associated cognitive impairment","volume":"27","author":"Greene","year":"2024","journal-title":"Nat Neurosci"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41392-021-00719-9","article-title":"Sars-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","article-title":"The blood\u2013brain barrier in systemic infection and inflammation","volume":"18","author":"Galea","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","article-title":"Cd147-spike protein is a novel route for Sars-CoV-2 infection to host cells","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41598-020-80464-1","article-title":"No evidence for basigin\/Cd147 as a direct Sars-CoV-2 spike binding receptor","volume":"11","author":"Shilts","year":"2021","journal-title":"Sci Rep"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1038\/s41380-022-01831-0","article-title":"Sars-CoV-2 drives Nlrp3 inflammasome activation in human microglia through spike protein","volume":"28","author":"Albornoz","year":"2023","journal-title":"Mol Psychiatry"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jama.2020.14254","article-title":"Neurology and Covid-19","volume":"324","author":"Josephson","year":"2020","journal-title":"JAMA"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11940-020-00647-z","article-title":"Unraveling the possible routes of Sars-Cov-2 invasion into the central nervous system","volume":"22","author":"Lima","year":"2020","journal-title":"Curr Treat Options Neurol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12931-020-01479-w","article-title":"From Sars and Mers to Covid-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses","volume":"21","author":"Zhu","year":"2020","journal-title":"Respir Res"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"103981","DOI":"10.1016\/j.ebiom.2022.103981","article-title":"Sars-CoV-2 entry sites are present in all structural elements of the human glossopharyngeal and vagal nerves: clinical implications","volume":"78","author":"Vitale-Cross","year":"2022","journal-title":"EBioMedicine"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/jmcb\/mjab044","article-title":"Emerging neurotropic features of Sars-CoV-2","volume":"13","author":"Zhan","year":"2021","journal-title":"J Mol Cell Biol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.abm8108","article-title":"The immunology and immunopathology of Covid-19","volume":"375","author":"Merad","year":"2022","journal-title":"Science"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e86014","DOI":"10.7554\/eLife.86014","article-title":"Immune mechanisms underlying Covid-19 pathology and post-acute sequelae of Sars-CoV-2 infection (Pasc)","volume":"12","author":"Mohandas","year":"2023","journal-title":"eLife"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"101873","DOI":"10.1016\/j.smim.2024.101873","article-title":"Systems analysis of innate and adaptive immunity in Long Covid","volume":"72","author":"Peluso","year":"2024","journal-title":"Semin Immunol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-2600(23)00239-4","article-title":"Post-acute sequelae of Covid-19: understanding and addressing the burden of multisystem manifestations","volume":"11","author":"Parotto","year":"2023","journal-title":"Lancet Respir Med"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41582-020-0398-3","article-title":"Lifting the mask on neurological manifestations of Covid-19","volume":"16","author":"Pezzini","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/neurolint15030052","article-title":"Long Covid, the brain, nerves, and cognitive function","volume":"15","author":"Reiss","year":"2023","journal-title":"Neurol Int"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbi.2020.12.031","article-title":"Can Sars-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?","volume":"95","author":"Burks","year":"2021","journal-title":"Brain Behav Immun"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s12276-021-00602-1","article-title":"Innate immune sensing of coronavirus and viral evasion strategies","volume":"53","author":"Kasuga","year":"2021","journal-title":"Exp Mol Med"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3390\/v3060920","article-title":"Pattern recognition receptors and the innate immune response to viral infection","volume":"3","author":"Thompson","year":"2011","journal-title":"Viruses"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s41232-023-00259-5","article-title":"Innate immune recognition against Sars-CoV-2","volume":"43","author":"Yamada","year":"2023","journal-title":"Inflamm Regen"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum David","year":"2020","journal-title":"N Engl J Med"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/vaccines9050436","article-title":"Role of inflammatory cytokines in Covid-19 patients: A review on molecular mechanisms, immune functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm","volume":"9","author":"Rabaan","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of Covid-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s10571-023-01444-3","article-title":"Microglial inflammatory responses to Sars\u2010CoV\u20102 infection: a comprehensive review","volume":"44","author":"Dey","year":"2023","journal-title":"Cell Mol Neurobiol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"102608","DOI":"10.1016\/j.conb.2022.102608","article-title":"Neuroinflammation and Covid-19","volume":"76","author":"Vanderheiden","year":"2022","journal-title":"Curr Opin Neurobiol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1038\/s41598-024-55696-0","article-title":"Severe Covid-19 and long Covid are associated with high expression of Sting, cgas and Ifn-\u03b1","volume":"14","author":"Queiroz","year":"2024","journal-title":"Sci Rep"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/imr.13114","article-title":"The nervous system during Covid-19: caught in the crossfire","volume":"311","author":"Natale","year":"2022","journal-title":"Immunol Rev"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1155770","DOI":"10.3389\/fimmu.2023.1155770","article-title":"Neuro-Pasc is characterized by enhanced Cd4+ and diminished Cd8+ T cell responses to Sars-CoV-2 Nucleocapsid protein","volume":"14","author":"Visvabharathy","year":"2023","journal-title":"Front Immunol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/biomedicines11020377","article-title":"Mechanisms, effects, and Management of Neurological Complications of post-acute sequelae of Covid-19 (Nc-Pasc)","volume":"11","author":"Ong","year":"2023","journal-title":"Biomedicine"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"988536","DOI":"10.3389\/fimmu.2022.988536","article-title":"The role of B cells in Covid-19 infection and vaccination","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"109183","DOI":"10.1016\/j.intimp.2022.109183","article-title":"Molecular mimicry, hyperactive immune system, and Sars-Cov-2 are three prerequisites of the autoimmune disease triangle following Covid-19 infection","volume":"112","author":"Vahabi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1367974","DOI":"10.3389\/fneur.2024.1367974","article-title":"Long Covid and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Neurol"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-023-00627-2","article-title":"The role of peripheral inflammatory insults in Alzheimer's disease: a review and research roadmap","volume":"18","author":"Walker","year":"2023","journal-title":"Mol Neurodegener"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.3390\/cells12222601","article-title":"Covid-19 and Alzheimer's disease share common neurological and ophthalmological manifestations: a bidirectional risk in the post-pandemic future","volume":"12","author":"Amadoro","year":"2023","journal-title":"Cells"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neurol.2020.10.001","article-title":"Neurological manifestations associated with Sars-CoV-2 and other coronaviruses: a narrative review for clinicians","volume":"177","author":"Maury","year":"2021","journal-title":"Rev Neurol (Paris)"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1007\/s12035-021-02450-6","article-title":"Emerging Covid-19 neurological manifestations: present outlook and potential neurological challenges in Covid-19 pandemic","volume":"58","author":"Dewanjee","year":"2021","journal-title":"Mol Neurobiol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of Covid-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.3390\/cells11162575","article-title":"Encephalitis in patients with Covid-19: a systematic evidence-based analysis","volume":"11","author":"Islam","year":"2022","journal-title":"Cells"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/diagnostics12040924","article-title":"Spectrum of hemorrhagic encephalitis in Covid-19 patients: a case series and review","volume":"12","author":"Sharma","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"e33365","DOI":"10.7759\/cureus.33365","article-title":"Acute disseminated encephalomyelitis following Covid-19 infection","volume":"15","author":"Assi","year":"2023","journal-title":"Cureus"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3390\/vaccines11071225","article-title":"The occurrence of acute disseminated encephalomyelitis in Sars-CoV-2 infection\/vaccination: our experience and a systematic review of the literature","volume":"11","author":"Stoian","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1097\/MS9.0000000000000953","article-title":"Cerebrovascular disease in patients with Covid-19 infection: a case series from Lebanon","volume":"85","author":"El Mawla","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"571996","DOI":"10.3389\/fneur.2020.571996","article-title":"Covid-19 associated ischemic stroke and hemorrhagic stroke: incidence, potential pathological mechanism, and management","volume":"11","author":"Wang","year":"2020","journal-title":"Front Neurol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13024-023-00674-9","article-title":"Microglial function, Inpp5D\/Ship1 signaling, and Nlrp3 inflammasome activation: implications for Alzheimer\u2019s disease","volume":"18","author":"Terzioglu","year":"2023","journal-title":"Mol Neurodegener"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"118","DOI":"10.11604\/pamj.supp.2020.35.2.25003","article-title":"Guillain-Barr\u00e9 syndrome associated with Covid-19 infection","volume":"35","author":"Manji","year":"2020","journal-title":"Pan Afr Med J"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.3390\/v13112225","article-title":"Covid-19 anosmia: high prevalence, plural Neuropathogenic mechanisms, and scarce Neurotropism of Sars-CoV-2?","volume":"13","author":"Liang","year":"2021","journal-title":"Viruses"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S1474-4422(21)00182-4","article-title":"Post-viral effects of Covid-19 in the olfactory system and their implications","volume":"20","author":"Xydakis","year":"2021","journal-title":"Lancet Neurol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"135531","DOI":"10.1016\/j.neulet.2020.135531","article-title":"Neuro-ophthalmologic complications of coronavirus disease 2019 (Covid-19)","volume":"742","author":"Gold","year":"2021","journal-title":"Neurosci Lett"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12886-022-02747-7","article-title":"Neuro-ophthalmologic symptoms after coronavirus disease 2019 vaccination: a retrospective study","volume":"23","author":"Kang","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.3390\/v14102255","article-title":"Rhabdomyolysis after Covid-19 infection: a case report and review of the literature","volume":"14","author":"Bawor","year":"2022","journal-title":"Viruses"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"112757","DOI":"10.1016\/j.biopha.2022.112757","article-title":"Muscle pain and muscle weakness in Covid19 patients: Cross-talk with statins \u2013 preliminary results","volume":"148","author":"Daria","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1287480","DOI":"10.3389\/fnins.2023.1287480","article-title":"Case report: a novel case of Covid-19 triggered tumefactive demyelinating lesions in one multiple sclerosis patient","volume":"17","author":"Hu","year":"2023","journal-title":"Front Neurosci"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"970383","DOI":"10.3389\/fneur.2022.970383","article-title":"Covid-19 and the risk of Cns demyelinating diseases: a systematic review","volume":"13","author":"Lotan","year":"2022","journal-title":"Front Neurol"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"15499","DOI":"10.3390\/ijerph192315499","article-title":"Brain fog and fatigue following Covid-19 infection: an exploratory study of patient experiences of Long Covid","volume":"19","author":"Chasco","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41419-024-06642-5","article-title":"Research progress of post-acute sequelae after Sars-CoV-2 infection","volume":"15","author":"Jiao","year":"2024","journal-title":"Cell Death Dis"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"812774","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3389\/fimmu.2018.01523","article-title":"Toll-like receptors, associated biological roles, and signaling networks in non-mammals","volume":"9","author":"Nie","year":"2018","journal-title":"Front Immunol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1157023","DOI":"10.1155\/2021\/1157023","article-title":"Toll-like receptors (Tlrs): structure, functions, signaling, and role of their polymorphisms in colorectal Cancer susceptibility","volume":"2021","author":"Sameer","year":"2021","journal-title":"Biomed Res Int"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12979-023-00383-3","article-title":"Toll-like receptor 4 (Tlr4): new insight immune and aging","volume":"20","author":"Kim","year":"2023","journal-title":"Immun Ageing"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.4110\/in.2020.20.e21","article-title":"Tlr10 and its unique anti-inflammatory properties and potential use as a target in therapeutics","volume":"20","author":"Fore","year":"2020","journal-title":"Immune Netw"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.3390\/v13102065","article-title":"Toll-like receptors in viral encephalitis","volume":"13","author":"Gern","year":"2021","journal-title":"Viruses"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"e00651-17","DOI":"10.1128\/IAI.00651-17","article-title":"Expression of toll-like receptor 2 by dendritic cells is essential for the DnaJ-\u0394A146Ply-mediated Th1 immune response against Streptococcus pneumoniae","volume":"86","author":"Wang","year":"2018","journal-title":"Infect Immun"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","article-title":"Dendritic cell migration in inflammation and immunity","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"2195019","DOI":"10.1080\/22221751.2023.2195019","article-title":"The role of dendritic cells in Covid-19 infection","volume":"12","author":"Wang","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nature06421","article-title":"Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis","volume":"450","author":"Sanjuan","year":"2007","journal-title":"Nature"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"15907","DOI":"10.1021\/jacs.2c07990","article-title":"Correction to \u201cnanoscale metal\u2013organic framework co-delivers TLR-7 agonists and anti-CD47 antibodies to modulate macrophages and orchestrate Cancer immunotherapy\u201d","volume":"144","author":"Ni","year":"2022","journal-title":"J Am Chem Soc"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3389\/fimmu.2018.01650","article-title":"Tlr-3 stimulation skews M2 macrophages to M1 through Ifn-\u03b1\u03b2 signaling and restricts tumor progression","volume":"9","author":"Vidyarthi","year":"2018","journal-title":"Front Immunol"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1038\/s41467-021-23683-y","article-title":"Tlr4 signalling via Piezo1 engages and enhances the macrophage mediated host response during bacterial infection","volume":"12","author":"Geng","year":"2021","journal-title":"Nat Commun"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.imlet.2023.07.003","article-title":"Human toll-like receptor 8 (Tlr8) in Nk cells: implication for cancer immunotherapy","volume":"261","author":"Veneziani","year":"2023","journal-title":"Immunol Lett"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"2045860","DOI":"10.1155\/2020\/2045860","article-title":"Toll-like receptors in natural killer cells and their application for immunotherapy","volume":"2020","author":"Noh","year":"2020","journal-title":"J Immunol Res"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity","volume":"2","author":"Akira","year":"2001","journal-title":"Nat Immunol"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.intimp.2018.03.002","article-title":"Toll-like receptors in immunity and inflammatory diseases: past, present, and future","volume":"59","author":"Vijay","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.3390\/ijms24076701","article-title":"The role of toll-like receptors (Tlrs) and their related signaling pathways in viral infection and inflammation","volume":"24","author":"Kircheis","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","article-title":"Damps and damp-sensing receptors in inflammation and diseases","volume":"57","author":"Ma","year":"2024","journal-title":"Immunity"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1600-065X.2006.00441.x","article-title":"Cns immune privilege: hiding in plain sight","volume":"213","author":"Carson","year":"2006","journal-title":"Immunol Rev"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuron.2013.04.005","article-title":"Innate immunity in the Cns: redefining the relationship between the Cns and its environment","volume":"78","author":"Lampron","year":"2013","journal-title":"Neuron"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"6824","DOI":"10.1038\/srep06824","article-title":"Toll-like receptors 2, \u22123 and \u22124 prime microglia but not astrocytes across central nervous system regions for Atp-dependent interleukin-1\u03b2 release","volume":"4","author":"Facci","year":"2014","journal-title":"Sci Rep"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fncel.2018.00329","article-title":"Role of microglia Tlrs in neurodegeneration","volume":"12","author":"Fiebich","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1042\/CS20110164","article-title":"Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential","volume":"121","author":"Hanke","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"742065","DOI":"10.3389\/fnins.2021.742065","article-title":"Microglia in Neuroinflammation and neurodegeneration: from understanding to therapy","volume":"15","author":"Muzio","year":"2021","journal-title":"Front Neurosci"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"34278","DOI":"10.1038\/srep34278","article-title":"Tlr4 signaling induces Tlr3 up-regulation in alveolar macrophages during acute lung injury","volume":"7","author":"Ding","year":"2017","journal-title":"Sci Rep"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"39727","DOI":"10.1074\/jbc.M405027200","article-title":"Lipopolysaccharide and double-stranded Rna up-regulate toll-like receptor 2 independently of myeloid differentiation factor 88*","volume":"279","author":"Nilsen","year":"2004","journal-title":"J Biol Chem"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.it.2012.03.001","article-title":"Toll-like receptor (Tlr) and inflammasome actions in the central nervous system","volume":"33","author":"Hanamsagar","year":"2012","journal-title":"Trends Immunol"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fimmu.2020.00724","article-title":"Tlr4 Cross-talk with Nlrp3 Inflammasome and complement signaling pathways in Alzheimer's disease","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The Nlrp3 Inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of Nlrp3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4103\/1673-5374.290881","article-title":"Microglia in neurodegenerative diseases","volume":"16","author":"Xu","year":"2021","journal-title":"Neural Regen Res"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"e0130624","DOI":"10.1371\/journal.pone.0130624","article-title":"Nlrp3 Inflammasome is expressed and functional in mouse brain microglia but not in astrocytes","volume":"10","author":"Gustin","year":"2015","journal-title":"PLoS One"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"948770","DOI":"10.3389\/fmicb.2022.948770","article-title":"Toll-like receptor signaling in severe acute respiratory syndrome coronavirus 2-induced innate immune responses and the potential application value of toll-like receptor Immunomodulators in patients with coronavirus disease 2019","volume":"13","author":"Dai","year":"2022","journal-title":"Front Microbiol"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"e839","DOI":"10.1002\/iid3.839","article-title":"Toll-like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential","volume":"11","author":"Dabi","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.tins.2008.01.005","article-title":"Toll-like receptors: roles in neuroprotection?","volume":"31","author":"Hanisch","year":"2008","journal-title":"Trends Neurosci"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s40478-020-01031-3","article-title":"Activation of toll-like receptor 5 in microglia modulates their function and triggers neuronal injury","volume":"8","author":"Ifuku","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.bbrc.2008.04.148","article-title":"Rock, Pak, and toll of synapses in Alzheimer's disease","volume":"371","author":"Salminen","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"577362","DOI":"10.1016\/j.jneuroim.2020.577362","article-title":"Toll-like receptors in Alzheimer's disease","volume":"348","author":"Momtazmanesh","year":"2020","journal-title":"J Neuroimmunol"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3389\/fimmu.2020.01588","article-title":"Role of toll like receptor 4 in Alzheimer\u2019s disease","volume":"11","author":"Calvo-Rodriguez","year":"2020","journal-title":"Front Immunol"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"115338","DOI":"10.1016\/j.biopha.2023.115338","article-title":"Toll-like receptor 4: a potential therapeutic target for multiple human diseases","volume":"166","author":"Wei","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"602508","DOI":"10.3389\/fnins.2020.602508","article-title":"Tlr4 targeting as a promising therapeutic strategy for Alzheimer disease treatment","volume":"14","author":"Zhou","year":"2020","journal-title":"Front Neurosci"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","article-title":"Tlr4 and Cd14 trafficking and its influence on Lps-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/jnc.13411","article-title":"The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease","volume":"136","author":"Minter","year":"2016","journal-title":"J Neurochem"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jns.2011.11.032","article-title":"Increased expressions of Tlr2 and Tlr4 on peripheral blood mononuclear cells from patients with Alzheimer's disease","volume":"315","author":"Zhang","year":"2012","journal-title":"J Neurol Sci"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.2174\/138161208786264089","article-title":"Association between the polymorphisms of Tlr4 and Cd14 genes and Alzheimer's disease","volume":"14","author":"Balistreri","year":"2008","journal-title":"Curr Pharm Des"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neulet.2005.08.047","article-title":"Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease","volume":"391","author":"Minoretti","year":"2006","journal-title":"Neurosci Lett"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3233\/JAD-171160","article-title":"Tlr4 gene expression and pro-inflammatory cytokines in Alzheimer\u2019s disease and in response to hippocampal Deafferentation in rodents","volume":"63","author":"Miron","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.expneurol.2008.05.014","article-title":"Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid \u03b2-peptide and the membrane lipid peroxidation product 4-hydroxynonenal","volume":"213","author":"Tang","year":"2008","journal-title":"Exp Neurol"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3892\/mmr.2013.1322","article-title":"The role of the Tlr4 signaling pathway in cognitive deficits following surgery in aged rats","volume":"7","author":"Wang","year":"2013","journal-title":"Mol Med Rep"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"7924199","DOI":"10.1155\/2022\/7924199","article-title":"Toll-like receptor 4: a promising therapeutic target for Alzheimer's disease","volume":"2022","author":"Wu","year":"2022","journal-title":"Mediat Inflamm"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1742-2094-10-101","article-title":"Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer's disease in Han Chinese","volume":"10","author":"Wang","year":"2013","journal-title":"J Neuroinflammation"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"5380","DOI":"10.1038\/s41380-023-02166-0","article-title":"Mutated toll-like receptor 9 increases Alzheimer\u2019s disease risk by compromising innate immunity protection","volume":"28","author":"Cacace","year":"2023","journal-title":"Mol Psychiatry"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1172\/JCI96209","article-title":"Selective disruption of Tlr2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology","volume":"128","author":"Rangasamy","year":"2018","journal-title":"J Clin Invest"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1084\/jem.20180484","article-title":"Tlr5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's disease","volume":"215","author":"Chakrabarty","year":"2018","journal-title":"J Exp Med"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-014-0090-1","article-title":"Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients","volume":"2","author":"Doorn","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/brain\/awab122","article-title":"Reactive microglia enhance the transmission of exosomal \u03b1-synuclein via toll-like receptor 2","volume":"144","author":"Xia","year":"2021","journal-title":"Brain"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00401-016-1648-8","article-title":"Toll-like receptor 2 is increased in neurons in Parkinson\u2019s disease brain and may contribute to alpha-synuclein pathology","volume":"133","author":"Dzamko","year":"2017","journal-title":"Acta Neuropathol"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000443238","article-title":"Decreased toll-like receptor 2 and toll-like receptor 7\/8-induced cytokines in Parkinson's disease patients","volume":"23","author":"Da Silva","year":"2016","journal-title":"Neuroimmunomodulation"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"pyu103","DOI":"10.1093\/ijnp\/pyu103","article-title":"Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson\u2019s disease","volume":"18","author":"Drouin-Ouellet","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"e00948","DOI":"10.1002\/brb3.948","article-title":"High expression of the Hmgb1\u2013Tlr4 axis and its downstream signaling factors in patients with Parkinson's disease and the relationship of pathological staging","volume":"8","author":"Yang","year":"2018","journal-title":"Brain Behav"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1038\/srep14764","article-title":"Induction of microglial toll-like receptor 4 by prothrombin kringle-2: a potential pathogenic mechanism in Parkinson\u2019s disease","volume":"5","author":"Shin","year":"2015","journal-title":"Sci Rep"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s40478-020-01083-5","article-title":"Neuroinflammation and protein pathology in Parkinson\u2019s disease dementia","volume":"8","author":"Kouli","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"313","DOI":"10.22034\/iji.2020.87454.1803","article-title":"Toll-like receptor (Tlr)-9 rs352140 polymorphism is an immunopathology protective factor in Parkinson's disease in the northern Iranian population","volume":"17","author":"Miri","year":"2020","journal-title":"Iran J Immunol"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1002\/jnr.24916","article-title":"Toll-like receptor 10 controls Tlr2-induced cytokine production in monocytes from patients with Parkinson's disease","volume":"99","author":"Da Rocha Sobrinho","year":"2021","journal-title":"J Neurosci Res"},{"key":"ref174","first-page":"75","article-title":"Role of toll-like receptors in multiple sclerosis","volume":"2","author":"Miranda-Hernandez","year":"2013","journal-title":"Am J Clin Exp Immunol"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jns.2016.12.027","article-title":"Tlr9 and its signaling pathway in multiple sclerosis","volume":"373","author":"Zhou","year":"2017","journal-title":"J Neurol Sci"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fimmu.2018.00457","article-title":"The soluble form of toll-like receptor 2 is elevated in serum of multiple sclerosis patients: a novel potential disease biomarker","volume":"9","author":"Hossain","year":"2018","journal-title":"Front Immunol"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neuroscience.2011.02.001","article-title":"Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue","volume":"179","author":"Casula","year":"2011","journal-title":"Neuroscience"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/mds.27911","article-title":"Association between toll-like receptor 4 (Tlr4) and triggering receptor expressed on myeloid cells 2 (Trem2) genetic variants and clinical progression of Huntington's disease","volume":"35","author":"Vuono","year":"2020","journal-title":"Mov Disord"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"7420189","DOI":"10.1155\/2019\/7420189","article-title":"Cell type specific expression of toll-like receptors in human brains and implications in Alzheimer's disease","volume":"2019","author":"Frederiksen","year":"2019","journal-title":"Biomed Res Int"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"198962","DOI":"10.1016\/j.virusres.2022.198962","article-title":"Sars-CoV-2 mediated dysregulation in cell signaling events drives the severity of Covid-19","volume":"323","author":"Aktar","year":"2023","journal-title":"Virus Res"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"745789","DOI":"10.3389\/fmed.2021.745789","article-title":"Neuroinflammation and its impact on the pathogenesis of Covid-19","volume":"8","author":"Almutairi","year":"2021","journal-title":"Front Med"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"10716","DOI":"10.3390\/ijms231810716","article-title":"Toll-like receptor mediation in Sars-CoV-2: a therapeutic approach","volume":"23","author":"Manan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"8065","DOI":"10.3390\/ijms24098065","article-title":"Tlrs: innate immune sentries against Sars-CoV-2 infection","volume":"24","author":"Mantovani","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/v14050999","article-title":"Sars-CoV-2 envelope (E) protein binds and activates Tlr2 pathway: a novel molecular target for Covid-19 interventions","volume":"14","author":"Plan\u00e8s","year":"2022","journal-title":"Viruses"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s12276-022-00755-7","article-title":"Does Sars-CoV-2 affect neurodegenerative disorders? Tlr2, a potential receptor for Sars-CoV-2 in the Cns","volume":"54","author":"Szabo","year":"2022","journal-title":"Exp Mol Med"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bbi.2023.04.009","article-title":"Exploring the immunogenic properties of SARS-CoV-2 structural proteins: PAMP:TLR signaling in the mediation of the neuroinflammatory and neurologic sequelae of COVID-19","volume":"111","author":"Frank","year":"2023","journal-title":"Brain Behav Immun"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","article-title":"Tlr2 senses the Sars-CoV-2 envelope protein to produce inflammatory cytokines","volume":"22","author":"Zheng","year":"2021","journal-title":"Nat Immunol"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/15257770.2022.2151015","article-title":"Toll-like receptor-2 (Tlr-2) rs111200466 variant offers protection against Sars-CoV-2 infections and mortality: a worldwide epidemiological correlation analysis","volume":"42","author":"Nayak","year":"2023","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2147\/JIR.S394927","article-title":"Impact of toll-like receptor 2 and 9 gene polymorphisms on Covid-19: susceptibility, severity, and thrombosis","volume":"16","author":"Alhabibi","year":"2023","journal-title":"J Inflamm Res"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"e21893","DOI":"10.1016\/j.heliyon.2023.e21893","article-title":"Sars-CoV-2 activates the Tlr4\/MyD88 pathway in human macrophages: a possible correlation with strong pro-inflammatory responses in severe Covid-19","volume":"9","author":"Sahanic","year":"2023","journal-title":"Heliyon"},{"key":"ref191","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/biomedicines11041078","article-title":"Reduced Il-8 secretion by nod-like and toll-like receptors in blood cells from Covid-19 patients","volume":"11","author":"Carreto-Binaghi","year":"2023","journal-title":"Biomedicine"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1080\/15548627.2021.1995152","article-title":"The polymorphism L412F in Tlr3 inhibits autophagy and is a marker of severe Covid-19 in males","volume":"18","author":"Croci","year":"2022","journal-title":"Autophagy"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12879-023-07980-z","article-title":"Predictive markers related to local and systemic inflammation in severe Covid-19-associated Ards: a prospective single-center analysis","volume":"23","author":"Lieberum","year":"2023","journal-title":"BMC Infect Dis"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s13577-021-00510-6","article-title":"Association of Tlr3 functional variant (rs3775291) with Covid-19 susceptibility and death: a population-scale study","volume":"34","author":"Dhangadamajhi","year":"2021","journal-title":"Hum Cell"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"15223","DOI":"10.1038\/s41598-021-94624-4","article-title":"Lower peripheral blood toll-like receptor 3 expression is associated with an unfavorable outcome in severe Covid-19 patients","volume":"11","author":"Menezes","year":"2021","journal-title":"Sci Rep"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"108929","DOI":"10.1016\/j.clim.2022.108929","article-title":"Prognostic impact of toll-like receptors gene polymorphism on outcome of Covid-19 pneumonia: a case-control study","volume":"235","author":"Alseoudy","year":"2022","journal-title":"Clin Immunol"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12879-022-07437-9","article-title":"Mrna expression of toll-like receptors 3, 7, 8, and 9 in the nasopharyngeal epithelial cells of coronavirus disease 2019 patients","volume":"22","author":"Bagheri-Hosseinabadi","year":"2022","journal-title":"BMC Infect Dis"},{"key":"ref198","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.3346\/jkms.2020.35.e343","article-title":"Covid-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial Sepsis","volume":"35","author":"Sohn","year":"2020","journal-title":"J Korean Med Sci"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"13259","DOI":"10.3390\/ijms241713259","article-title":"The role of toll-like Receptor-4 in macrophage imbalance in lethal Covid-19 lung disease, and its correlation with Galectin-3","volume":"24","author":"Pedicillo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1161\/CIRCRESAHA.122.321541","article-title":"Toll-like receptor 4-dependent platelet-related thrombosis in Sars-CoV-2 infection","volume":"132","author":"Carnevale","year":"2023","journal-title":"Circ Res"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijid.2023.11.032","article-title":"Variant rs4986790 of toll-like receptor 4 affects the signaling and induces cell dysfunction in patients with severe Covid-19","volume":"138","author":"Flores-Gonzalez","year":"2024","journal-title":"Int J Infect Dis"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"1355193","DOI":"10.3389\/fimmu.2024.1355193","article-title":"The single nucleotide polymorphism rs4986790 (c.896A>G) in the gene Tlr4 as a protective factor in corona virus disease 2019 (Covid-19)","volume":"15","author":"Zacher","year":"2024","journal-title":"Front Immunol"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"96","DOI":"10.53854\/liim-3001-11","article-title":"Comparison of Covid-19 characteristics in Egyptian patients according to their toll-like Receptor-4 (Asp299Gly) polymorphism","volume":"30","author":"Taha","year":"2022","journal-title":"Infez Med"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"201115","DOI":"10.1016\/j.humgen.2022.201115","article-title":"Association of Toll-like receptor-4 polymorphism with Sars CoV-2 infection in Kurdish population","volume":"34","author":"Ali","year":"2022","journal-title":"Hum Gene (Amst)"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41479-023-00121-9","article-title":"Serum soluble toll-like receptor 4 and risk for clinical severity in Covid-19 patients","volume":"16","author":"Houssen","year":"2024","journal-title":"Pneumonia (Nathan)"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"e12653","DOI":"10.1016\/j.heliyon.2022.e12653","article-title":"Association between the expression of toll-like receptors, cytokines, and homeostatic chemokines in Sars-CoV-2 infection and Covid-19 severity","volume":"9","author":"Alturaiki","year":"2023","journal-title":"Heliyon"},{"key":"ref207","doi-asserted-by":"publisher","first-page":"e67569","DOI":"10.7554\/eLife.67569","article-title":"Association of Toll-like receptor 7 variants with life-threatening Covid-19 disease in males: findings from a nested case-control study","volume":"10","author":"Fallerini","year":"2021","journal-title":"eLife"},{"key":"ref208","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41435-021-00157-1","article-title":"Rare variants in toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in Covid-19 patients","volume":"23","author":"Mantovani","year":"2022","journal-title":"Genes Immun"},{"key":"ref209","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12985-021-01656-3","article-title":"Case report: hepatitis in a child infected with Sars-CoV-2 presenting toll-like receptor 7 Gln11Leu single nucleotide polymorphism","volume":"18","author":"Pessoa","year":"2021","journal-title":"Virol J"},{"key":"ref210","doi-asserted-by":"publisher","first-page":"101612","DOI":"10.1016\/j.genrep.2022.101612","article-title":"Covid-19 susceptibility, severity, clinical outcome and toll-like receptor (7) mrna expression driven by Tlr7 gene polymorphism (rs3853839) in middle-aged individuals without previous comorbidities","volume":"27","author":"El-Hefnawy","year":"2022","journal-title":"Gene Rep"},{"key":"ref211","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.3390\/diagnostics13233510","article-title":"No association between Sars-CoV-2 infection and the polymorphism of the toll-like receptor 7 (Tlr7) gene in female population","volume":"13","author":"Zayed","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"ref212","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1080\/15257770.2023.2176515","article-title":"The investigation of host genetic variants of toll-like receptor 7 and 8 in Covid-19","volume":"42","author":"Bagci","year":"2023","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref213","first-page":"71","article-title":"Tlr8 is highly conserved among the Saudi population and its mutations have no effect on the severity of Covid-19 symptoms","volume":"10","author":"Mahallawi","year":"2021","journal-title":"Am J Clin Exp Immunol"},{"key":"ref214","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamapsychiatry.2023.1321","article-title":"Neuroinflammation after Covid-19 with persistent depressive and cognitive symptoms","volume":"80","author":"Braga","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"ref215","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41398-023-02692-z","article-title":"Amyloid precursor protein facilitates Sars-CoV-2 virus entry into cells and enhances amyloid-\u03b2-associated pathology in app\/Ps1 mouse model of Alzheimer\u2019s disease","volume":"13","author":"Chen","year":"2023","journal-title":"Transl Psychiatry"},{"key":"ref216","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1038\/s41467-022-30932-1","article-title":"Neurotoxic amyloidogenic peptides in the proteome of Sars-Cov2: potential implications for neurological symptoms in Covid-19","volume":"13","author":"Charnley","year":"2022","journal-title":"Nat Commun"},{"key":"ref217","doi-asserted-by":"publisher","first-page":"13603","DOI":"10.3390\/ijms222413603","article-title":"Sars-CoV-2 exacerbates Beta-amyloid neurotoxicity, inflammation and oxidative stress in Alzheimer\u2019s disease patients","volume":"22","author":"Chiricosta","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref218","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3390\/metabo12111099","article-title":"Sars-CoV-2-induced Amyloidgenesis: not one, but three hypotheses for cerebral Covid-19 outcomes","volume":"12","author":"Gon\u00e7alves","year":"2022","journal-title":"Meta"},{"key":"ref219","doi-asserted-by":"publisher","first-page":"8945","DOI":"10.1021\/jacs.2c03925","article-title":"Amyloidogenesis of Sars-CoV-2 spike protein","volume":"144","author":"Nystr\u00f6m","year":"2022","journal-title":"J Am Chem Soc"},{"key":"ref220","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"ref221","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms23179739","article-title":"Post-Covid-19 parkinsonism and Parkinson's disease pathogenesis: the Exosomal cargo hypothesis","volume":"23","author":"Mysiris","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref222","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.tins.2022.10.007","article-title":"Interferon \u03b3: a master cytokine in microglia-mediated neural network dysfunction and neurodegeneration","volume":"45","author":"Kann","year":"2022","journal-title":"Trends Neurosci"},{"key":"ref223","doi-asserted-by":"publisher","first-page":"1268035","DOI":"10.3389\/fneur.2023.1268035","article-title":"Novel Tlr7 hemizygous variant in post-Covid-19 neurological deterioration: a case report with literature review","volume":"14","author":"Noor Eddin","year":"2023","journal-title":"Front Neurol"},{"key":"ref224","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/14728222.2021.1918103","article-title":"Tlr4 as a therapeutic target for respiratory and neurological complications of Sars-CoV-2","volume":"25","author":"Kaushik","year":"2021","journal-title":"Expert Opin Ther Targets"},{"key":"ref225","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s11427-022-2219-0","article-title":"Orally administered Bzl-srna-20 oligonucleotide targeting Tlr4 effectively ameliorates acute lung injury in mice","volume":"66","author":"Zhao","year":"2023","journal-title":"Sci China Life Sci"},{"key":"ref226","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/cpt.2606","article-title":"Applying modeling and simulations for rational dose selection of novel toll-like receptor 7\/8 inhibitor Enpatoran for indications of high medical need","volume":"112","author":"Klopp-Schulze","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"ref227","doi-asserted-by":"publisher","first-page":"e00842","DOI":"10.1002\/prp2.842","article-title":"Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8","volume":"9","author":"Port","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"ref228","doi-asserted-by":"publisher","first-page":"103153","DOI":"10.1016\/j.ebiom.2020.103153","article-title":"Prophylactic intranasal administration of a Tlr2\/6 agonist reduces upper respiratory tract viral shedding in a Sars-CoV-2 challenge ferret model","volume":"63","author":"Proud","year":"2021","journal-title":"EBioMedicine"},{"key":"ref229","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1039\/D1CC06520C","article-title":"Rbd conjugate vaccine with a built-in Tlr1\/2 agonist is highly immunogenic against Sars-CoV-2 and variants of concern","volume":"58","author":"Zhou","year":"2022","journal-title":"Chem Commun (Camb)"},{"key":"ref230","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1165\/rcmb.2020-0247LE","article-title":"Inducible epithelial resistance against coronavirus pneumonia in mice","volume":"63","author":"Evans","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref231","doi-asserted-by":"publisher","first-page":"756315","DOI":"10.3389\/fcell.2021.756315","article-title":"Toll-like receptors as a therapeutic target in the era of immunotherapies","volume":"9","author":"Farooq","year":"2021","journal-title":"Front Cell Develop Biol"},{"key":"ref232","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41598-020-57714-3","article-title":"Tak-242, a specific inhibitor of toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice","volume":"10","author":"Ono","year":"2020","journal-title":"Sci Rep"},{"key":"ref233","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1021\/acs.molpharmaceut.0c01256","article-title":"Toll-like Receptor-4 (Tlr4) agonist-based intranasal Nanovaccine delivery system for inducing systemic and mucosal immunity","volume":"18","author":"Bakkari","year":"2021","journal-title":"Mol Pharm"},{"key":"ref234","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41541-021-00399-0","article-title":"Development of Covid-19 vaccine using a dual toll-like receptor ligand liposome adjuvant","volume":"6","author":"Abhyankar","year":"2021","journal-title":"npj Vaccines"},{"key":"ref235","doi-asserted-by":"publisher","first-page":"104897","DOI":"10.1016\/j.yexmp.2024.104897","article-title":"Effects of toll-like receptor agonists and Sars-CoV-2 antigens on interferon (Ifn) expression by peripheral blood Cd3+ T cells from Covid-19 patients","volume":"137","author":"Abdolmohammadi-Vahid","year":"2024","journal-title":"Exp Mol Pathol"},{"key":"ref236","doi-asserted-by":"publisher","first-page":"989664","DOI":"10.3389\/fphar.2022.989664","article-title":"Toll-like receptor (Tlrs) agonists and antagonists for Covid-19 treatments","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref237","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.expneurol.2018.07.016","article-title":"Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains","volume":"309","author":"Walker","year":"2018","journal-title":"Exp Neurol"},{"key":"ref238","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.2147\/JIR.S343246","article-title":"Toll-like receptor 4 polymorphisms (896A\/G and 1196C\/T) as an Indicator of Covid-19 severity in a convenience sample of Egyptian patients","volume":"14","author":"Taha","year":"2021","journal-title":"J Inflamm Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1458281\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T09:57:53Z","timestamp":1742983073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1458281\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":238,"alternative-id":["10.3389\/fmed.2025.1458281"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1458281","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"article-number":"1458281"}}